Alavi Hamed 4
4 · enVVeno Medical Corp · Filed Mar 15, 2024
Insider Transaction Report
Form 4
Alavi Hamed
Chief Technology Officer
Transactions
- Sale
Common Stock
2024-03-13$6.22/sh−8,334$51,837→ 0 total - Exercise/Conversion
Common Stock
2024-03-13$3.59/sh+8,334$29,919→ 8,334 total - Exercise/Conversion
Stock Options
2024-03-13−8,334→ 91,666 totalExercise: $3.59Exp: 2033-12-05→ Common Stock (8,334 underlying)
Footnotes (1)
- [F1]The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the Amended and Restated 2016 Omnibus Incentive Plan. The award is subject to time-based vesting and will vest in equal quarterly installments during the three calendar years through 2026. The portion of the stock options exercised in this transaction was fully vested and exercisable on the transaction date.